Patrons of The Lead-Lag Report would recollect that in this week's edition I've talked up the prospects of the healthcare segment. A slowing job market and the prospect of likely healthcare reform under a Democrat-controlled Congress have resulted in some interest coming back to this sector. So much so that the chart measuring the performance of healthcare stocks to the S&P 500 is on the cusp of breaking past the crucial 20MA (moving average), something it has lagged since late May-2020.
The stock I'll be covering today - AMN Healthcare (NYSE:AMN) - is part of this broad healthcare universe and one that I had written about more than six months back. For the uninitiated, AMN is the nationwide leader in the healthcare staffing market - essentially, the company serves as an intermediary in an industry where there is a growing demand-supply mismatch of labor. I thought it would be a good time to revisit the AMN story and update investors with recent developments.
Topline guidance scaled up by ~8% earlier this week
AMN is due to announce its Q4 results sometime in February, but what's noteworthy is that a few days back they recently scaled up their estimates beyond their previous guidance. Back in November, they had guided to a Q4 revenue range of ~$575m to $585m. This would have implied a flattish to ~-2% YoY decline relative to last year's Q4 of $589m. Now AMN expects to deliver $623m to $628m, an ~8% uptick from the mid-point of the previous guidance, which would also represent ~6.5% annual growth.
In addition to this, AMN also had previously guided to an expected EBITDA margin range of 13.3%-13.8%, now they've become slightly more specific and say that the Q4 margin will likely be toward the higher end of this range. As you can see from
Anticipate Crashes, Corrections, and Bear Markets
Sometimes, you might not realize your biggest portfolio risks until it’s too late.
That’s why it’s important to pay attention to the right market data, analysis, and insights on a daily basis. Being a passive investor puts you at unnecessary risk. When you stay informed on key signals and indicators, you'll take control of your financial future.
My award-winning market research gives you everything you need to know each day, so you can be ready to act when it matters most.
Click here to gain access and try the Lead-Lag Report FREE for 14 days.